KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Minority Interest (2016 - 2025)

Abbott Laboratories' Minority Interest history spans 17 years, with the latest figure at $641.0 million for Q4 2025.

  • For Q4 2025, Minority Interest rose 170.46% year-over-year to $641.0 million; the TTM value through Dec 2025 reached $641.0 million, up 170.46%, while the annual FY2025 figure was $641.0 million, 170.46% up from the prior year.
  • Minority Interest for Q4 2025 was $641.0 million at Abbott Laboratories, up from $310.0 million in the prior quarter.
  • Across five years, Minority Interest topped out at $641.0 million in Q4 2025 and bottomed at $209.0 million in Q3 2022.
  • The 5-year median for Minority Interest is $229.5 million (2021), against an average of $253.9 million.
  • The largest annual shift saw Minority Interest fell 3.48% in 2023 before it surged 170.46% in 2025.
  • A 5-year view of Minority Interest shows it stood at $222.0 million in 2021, then decreased by 1.35% to $219.0 million in 2022, then rose by 2.28% to $224.0 million in 2023, then grew by 5.8% to $237.0 million in 2024, then soared by 170.46% to $641.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABT's Minority Interest are $641.0 million (Q4 2025), $310.0 million (Q3 2025), and $264.0 million (Q2 2025).